
Improved screening and an ageing population has lead to more people than ever before being diagnosed with and treated for cancer. The cost of cancer treatment is climbing steeply as there are many new and expensive cancer drugs coming onto the market. Both medical insurers and the NHS are feeling the strain and so the debate has begun as to how cancer treatment should be funded in the future.
Here is a list of the directors of Beckett Investment Management Group. Please click on one of their names to find out more.